BeStock  

ANI Pharmaceuticals ANIP

US equityMarket cap rank #2847Drug Manufacturers - Specialty & Generic
$68.55 −$0.58 (-0.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $68.55 0.00%
Open$68.96
Prev close$69.13
Day range$68.28 – $70.20
Volume227.3K
Market cap$1.56B
P/E (TTM)13.6
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$290.78M+27.6% YoY
Operating profit$51.84M+127.0% YoY
Net profit$35.15M+32.1% YoY
Diluted EPS$1.51+33.6% YoY
Free cash flow$70.28M+85.5% YoY
Operating cash flow$83.79M

Revenue, last 8 quarters

$190.6MDec '24$197.1MMar '25$211.4MJun '25$227.8MSep '25$247.1MDec '25$237.5MMar '26$266.0MJun '26$290.8MSep '26

Net profit, last 8 quarters

$-10.3MDec '24$15.7MMar '25$8.5MJun '25$26.6MSep '25$27.5MDec '25$29.5MMar '26$24.7MJun '26$35.1MSep '26

Diluted EPS by quarter

-0.55Dec '240.69Mar '250.36Jun '251.13Sep '251.18Dec '251.28Mar '261.05Jun '261.51Sep '26

Free cash flow by quarter

$13.4MDec '24$15.1MMar '25$68.9MJun '25$37.9MSep '25$29.0MDec '25$47.1MMar '26$53.6MJun '26$70.3MSep '26

Annual revenue

$208.5MFY20$216.1MFY21$316.4MFY22$486.8MFY23$614.4MFY24$883.4MFY25

Profitability & balance sheet

Gross margin61.1%
Operating margin15.3%
Net margin10.6%
Return on equity19.2%
Return on assets7.4%
Return on invested capital10.2%
Current ratio2.75
Liabilities / assets59.4%
Cash & investments$436.35M
Total debt$607.23M
Net cash (debt)-$170.88M
Free cash flow / sales19.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Rare Disease and Brands$182.35M 62.7%
  • Generics and Other$108.43M 37.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $290.78M $266.04M $237.46M $883.37M $247.06M
Total Operating Revenue $290.78M $266.04M $237.46M $883.37M $247.06M
Cost of Revenue $111.53M $100.16M $93.58M $341.31M $100.27M
Gross Profit $179.25M $165.89M $143.88M $542.06M $146.79M
Operating Expense $127.41M $126.05M $105.17M $460.83M $117.66M
Selling and Admin Expenses $94.86M $91.66M $73.66M $317.75M $82.79M
Research & Development $13.00M $14.75M $10.60M $51.66M $12.26M
Depreciation & Amortization & Depletion $19.55M $19.64M $20.92M $91.42M $22.61M
-Depreciation & Amortization $19.55M $19.64M $20.92M $91.42M $22.61M
Operating Profit $51.84M $39.84M $38.71M $81.23M $29.13M
Net Non-Operating Interest Income (Expense) -$3.06M -$3.64M -$3.77M -$20.06M -$4.41M
Non-Operating Interest Expense $3.06M $3.64M $3.77M $20.06M $4.41M
Other Income (Expense) $262,000.00 $895,000.00 $5.28M $34.62M $6.76M
Gain on Sale of Security -$35,000.00 $741,000.00 $5.75M $2.82M $273,000.00
Special Income (Charges) $538,000.00 $622,000.00 $182,000.00 $29.86M $5.64M
-Less:Restructuring and Mergern & Acquisition -$538,000.00 -$622,000.00 -$182,000.00 -$31.01M -$5.73M
-Less:Impairment of Capital Assets $0.00 – – $767,000.00 $0.00
-Gain on Sale of Property/Plant/Equipment $0.00 – – -$382,000.00 -$87,000.00
Other Non-Operating Income (Expenses) -$241,000.00 -$468,000.00 -$651,000.00 $1.93M $850,000.00
Pretax Profit $49.04M $37.10M $40.22M $95.79M $31.48M
Tax $13.89M $12.39M $10.73M $17.45M $3.99M
Net Profit $35.15M $24.71M $29.49M $78.34M $27.49M
Profit from Continuing Operations $35.15M $24.71M $29.49M $78.34M $27.49M
Net Income to Parent Company $35.15M $24.71M $29.49M $78.34M $27.49M
Net Income to Common Stockholders $35.15M $23.00M $29.49M $70.22M $20.53M
Basic EPS $1.54 $1.09 $1.31 $3.50 $1.24
Diluted EPS $1.51 $1.05 $1.28 $3.32 $1.18
Other Preferred Stock Dividends – $1.71M – $6.96M –
Preferred Stock Dividends – – – $1.16M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.57B $1.49B $1.42B $1.44B $1.44B
Total Current Assets $902.82M $825.43M $747.08M $753.12M $753.12M
Cash and Cash Equivalents & Short-Term Investments $436.35M $375.84M $326.06M $294.72M $294.72M
-Cash and Cash Equivalents $420.76M $360.21M $311.18M $285.59M $285.59M
-Short Term Investments $15.59M $15.63M $14.89M $9.13M $9.13M
Receivables $304.45M $274.47M $255.43M $281.08M $281.08M
-Accounts Receivable $304.45M $274.47M $255.43M $281.08M $281.08M
Inventory $136.41M $143.15M $143.47M $143.07M $143.07M
Restricted Cash $35,000.00 $35,000.00 $36,000.00 $36,000.00 $36,000.00
Other Current Assets $25.58M $31.94M $22.09M $23.19M $23.19M
Total Non-Current Assets $664.84M $668.68M $674.89M $687.26M $687.26M
Net PPE $81.55M $73.22M $67.12M $62.48M $62.48M
Goodwill and Other Intangible Assets $495.59M $512.34M $529.64M $542.01M $542.01M
-Goodwill $62.48M $62.48M $62.48M $62.48M $62.48M
-Other Intangible Assets $433.11M $449.86M $467.16M $479.53M $479.53M
Non-Current Deferred Assets $74.67M $71.50M $66.56M $69.07M $69.07M
Other Non-Current Assets $13.03M $11.62M $11.58M – –
Total Liabilities $930.55M $896.90M $859.67M $899.65M $899.65M
Total Current Liabilities $328.72M $283.66M $239.51M $278.11M $278.11M
Payables $83.39M $77.36M $74.99M $64.82M $64.82M
-Accounts Payable $74.42M $73.83M $69.69M $62.58M $62.58M
-Total Tax Payable $8.98M $3.53M $5.30M $2.24M $2.24M
Current Accrued Expenses $141.36M $113.80M $86.08M $108.45M $108.45M
Short-Term Debt and Capital Lease Obligation $23.36M $21.33M $19.30M $17.27M $17.27M
-Current Debt $23.36M $21.33M $19.30M $17.27M $17.27M
Current Provisions $45.65M $44.01M $43.05M $49.50M $49.50M
Total Non-Current Liabilities $601.83M $613.25M $620.16M $621.54M $621.54M
Long Term Debt and Capital Lease Obligation $583.87M $589.16M $594.46M $599.77M $599.77M
-Long Term Debt $583.87M $589.16M $594.46M $599.77M $599.77M
Other Non-Current Liabilities $17.96M $24.08M $25.70M $21.77M $21.77M
Total Equity $637.11M $597.21M $562.30M $540.72M $540.72M
Stockholders' Equity $637.11M $597.21M $562.30M $540.72M $540.72M
Capital Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $634.24M $620.25M $608.43M $596.04M $596.04M
Retained Earnings $66.25M $31.10M $6.39M -$23.10M -$23.10M
Less: Treasury Stock -$62.21M -$53.82M -$53.00M -$33.25M -$33.25M
Gains/Losses Not Affecting Retained Earnings -$1.17M -$327,000.00 $479,000.00 $1.03M $1.03M
Prepaid Assets – – – $11.03M $11.03M
-Gross PPE – – – $115.17M $115.17M
-Accumulated Depreciation – – – -$52.69M -$52.69M
Financial Assets – – – $13.71M $13.71M
Other Current Liabilities – – – $167,000.00 $167,000.00
Non-Current Accrued Expenses – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $83.79M $56.67M $58.38M $185.23M $30.37M
Net cash flow from continuing operations $83.79M $56.67M $58.38M $185.23M $30.37M
Net Income from Continuing Operations $35.15M $24.71M $29.49M $78.34M $27.49M
Depreciation & Depletion & Amortization $19.55M $19.64M $20.92M $91.42M $22.61M
Deferred Tax -$3.17M -$4.94M $2.52M $14.24M $2.36M
Other Non-Cash Items $287,000.00 $191,000.00 $629,000.00 -$27.90M -$4.82M
Change in Working Capital $20.31M $6.40M $382,000.00 -$7.12M -$26.85M
-Change in Receivables -$30.05M -$19.08M $25.53M -$58.53M -$27.86M
-Change in Inventory $6.72M $305,000.00 -$437,000.00 -$5.96M $3.73M
-Change in Prepaid Assets $4.56M -$10.33M $2.69M -$5.02M -$4.46M
-Change in Payables and Accrued Expense $32.01M $22.23M -$20.95M $67.69M $1.76M
-Change In Other Working Capital $7.07M $13.28M -$6.45M -$5.30M -$30,000.00
Net cash flow from investing -$13.50M -$3.05M -$11.32M -$34.32M -$1.40M
Net Cash Flow from Continuing Investing Activities -$13.50M -$3.05M -$11.32M -$34.32M -$1.40M
Net PPE Purchase and Sale -$13.50M -$3.05M -$6.07M -$13.84M -$1.24M
Net Intangibles Purchase and Sale $0.00 $0.00 -$5.25M -$20.49M -$159,000.00
Financing Cash Flow -$9.83M -$4.65M -$21.62M -$9.94M -$4.64M
Net Cash Flow from Continuing Financing Activities -$9.83M -$4.65M -$21.62M -$9.94M -$4.64M
Net Issuance Payments Of Debt -$4.06M -$4.06M -$4.06M -$10.16M -$4.06M
Cash Dividends Paid $0.00 $0.00 $0.00 -$1.16M $0.00
Proceeds from Stock Option Exercised $1.30M -$20.26M $2.20M $13.60M $11.64M
Net Other Financing Charges -$77,000.00 – – -$26,000.00 $0.00
Ending Cash Balance $420.79M $360.25M $311.21M $285.62M $285.62M
Net Change in Cash $60.46M $48.97M $25.44M $140.96M $24.33M
Beginning Cash Balance $360.25M $311.21M $285.62M $144.89M $262.65M
Effect of Exchange Rate Changes $91,000.00 $67,000.00 $156,000.00 -$233,000.00 -$1.35M
Free Cash Flow $70.28M $53.62M $47.05M $150.90M $28.96M
Net Common Stock Issuance – – -$19.76M -$12.21M -$12.21M
Gain/Loss from Continuing Operations – – – $382,000.00 $87,000.00
Net Business Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on ANIP.

Sign in to join the discussion.

Scroll to Top